Stock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech-To The Moon - Tiger Brokers Online Investing Community

1
1
Favorite

Stock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech

Stock Track03-07

Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.

In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.

The insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

Dumplinggogh
·03-07
Need a miracle for this stock
Reply
1
Report

7x24

All

20:37
Uruguay's Dlocal Announces Extraordinary Dividend of $150 Million, or About $0.5251 per Share - Filing
20:36
LKQ Corp - Investor Parties to Abide by Standstill Restrictions IF Sue Gove and Michael Powell Renominated - SEC Filing
20:36
LKQ Corp - Enters Amendment to Cooperation Agreement With Ancora Catalyst Institutional, Engine Capital
20:34
Corby Spirit and Wine Limited Reports Its Fiscal 2025 Third Quarter Results for the Period Ended March 31, 2025, and Announces Quarterly Dividend of $0.23 per Share
20:34
Corby Spirit and Wine Q3 EPS CAD 0.14

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1105660960?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-07 23:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105660960","market":"us","top_or_hot":-1,"title":"Stock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech","media":"Stock Track","content":"<p>Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.</p>\n\n<p>In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.</p>\n\n<p>The insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-07 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.</p>\n\n<p>In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.</p>\n\n<p>The insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1105660960","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105660960","pubTimestamp":1741360347,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Moderna Inc.  surged 5.03% in Friday's trading session amidst positive news for the biotech company.In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patente","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"首席执行官购买股票并赢得针对辉瑞/BioNTech的专利诉讼，Moderna股价飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.\nIn a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.\nThe insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":410972759679032,"gmtCreate":1741368270997,"gmtModify":1741368274871,"author":{"id":"4088555865224950","authorId":"4088555865224950","name":"Dumplinggogh","avatar":"https://static.tigerbbs.com/a4148d32bdc2876cba031551925cd7e2","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"4088555865224950","idStr":"4088555865224950"},"htmlText":"Need a miracle for this stock&nbsp;","listText":"Need a miracle for this stock&nbsp;","text":"Need a miracle for this stock","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/410972759679032","repostId":1105660960,"repostType":2,"repost":{"id":"1105660960","kind":"news","weMediaInfo":{"introduction":"Track stock‘s movements and relevant news","home_visible":1,"media_name":"Stock Track","id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"pubTimestamp":1741360347,"share":"https://ttm.financial/m/news/1105660960?lang=&edition=full_marsco","pubTime":"2025-03-07 23:12","market":"us","language":"en","title":"Stock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=1105660960","media":"Stock Track","summary":"Shares of Moderna Inc.  surged 5.03% in Friday's trading session amidst positive news for the biotech company.In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patente","content":"<p>Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.</p>\n\n<p>In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.</p>\n\n<p>The insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.</p>","source":"ai_movement_en","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 5% as CEO Buys Shares and Wins Patent Case Against Pfizer/BioNTech\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-07 23:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.</p>\n\n<p>In a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.</p>\n\n<p>The insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105660960","content_text":"Shares of Moderna Inc. (MRNA) surged 5.03% in Friday's trading session amidst positive news for the biotech company.\nIn a vote of confidence, Moderna CEO Stephane Bancel and board member Paul Sagan purchased over $6 million worth of the company's shares this week according to SEC filings. Additionally, Moderna secured a favorable legal outcome in a patent dispute with Pfizer and BioNTech over its Covid-19 vaccine technology. A German court ruled that the two pharma giants infringed on Moderna's patented technology, requiring them to compensate the biotech firm, with the amount to be determined in further proceedings.\nThe insider buying and legal victory likely fueled investor optimism and drove Moderna's stock higher in Friday's trading. The episode highlights confidence from leadership as well as bolstered prospects for future revenue streams from the patent win against rivals.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":1,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}